Journal Specialty Index  

Haematology

Topic Issue
Update on the Treatment Strategies for Follicular Lymphoma SEPTEMBER 2020 ‧ VOL. 12 ‧ NO. 8
Haematological Manifestations of COVID-19 SEPTEMBER 2020 ‧ VOL. 12 ‧ NO. 8
More Anti-Myeloma Agents in 2019/2020 SEPTEMBER 2020 ‧ VOL. 12 ‧ NO. 8
Cancer-Associated Thrombosis Treatment Decision Pathway JANUARY 2020 ‧ VOL. 12 ‧ NO. 1
Myeloma: No Pain, More Gain NOVEMBER 2019 ‧ VOL. 11 ‧ NO. 8
A Novel Antibody-Drug Conjugate Shows Promise for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma SEPTEMBER 2019 ‧ VOL. 11 ‧ NO. 6
Novel Targeted Therapies for Acute Myeloid Leukaemia SEPTEMBER 2019 ‧ VOL. 11 ‧ NO. 6
Recognizing Immune-Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors SEPTEMBER 2019 ‧ VOL. 11 ‧ NO. 6
Update on the Management of Adult Acute Lymphoblastic Leukaemia SEPTEMBER 2018 ‧ VOL. 10 ‧ NO. 6
A Step Forward for the Management of Patients with Follicular Lymphoma? SEPTEMBER 2018 ‧ VOL. 10 ‧ NO. 6
Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agent (Venetoclax) SEPTEMBER 2018 ‧ VOL. 10 ‧ NO. 6
Curing Blood Cancers: No More Chemotherapy NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7
Rituximab for Subcutaneous Use: New Route of Administration SEPTEMBER 2017 ‧ VOL. 9 ‧ NO. 6
Good's Syndrome: An Acquired Immunodeficiency Associated with Thymomas SEPTEMBER 2017 ‧ VOL. 9 ‧ NO. 6
Novel Oral Therapies for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia SEPTEMBER 2017 ‧ VOL. 9 ‧ NO. 6
Consensus Statements on the Prevention and Management of NOAC-Associated Bleeding in General Practice in Hong Kong MARCH 2017 ‧ VOL. 9 ‧ NO. 2
Blood Cancers: No More Chemotherapy? NOVEMBER 2016 ‧ VOL. 8 ‧ NO. 7
Overview of IgG4-related Disease: A Novel Entity JULY 2016 ‧ VOL. 8 ‧ NO. 5
Hodgkin Lymphoma and Use of Brentuximab Vedotin in its Treatment JANUARY 2016 ‧ VOL. 8 ‧ NO. 1
Lymphoma: New Age, New Drugs, New Survival NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
Update in the Management of Chronic Lymphocytic Leukaemia (CLL) MAY 2015 ‧ VOL. 7 ‧ NO. 3
Improving Outcome and Quality of Life in Haematological Malignancies in the Elderly NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 6
Update in the Management of Mantle Cell Lymphoma JUNE 2014 ‧ VOL. 6 ‧ NO. 3
Bendamustine: The Gift from Behind the Iron Curtain JANUARY 2014 ‧ VOL. 6 ‧ NO. 1
Update on the Treatment of Chronic Myeloid Leukaemia JANUARY 2014 ‧ VOL. 6 ‧ NO. 1
Perioperative Management of Patients on Novel Oral Anticoagulants JANUARY 2014 ‧ VOL. 6 ‧ NO. 1
Supportive Care in Haematological Malignancies DECEMBER 2013 ‧ VOL. 5 ‧ NO. 7
Updates in Lymphoplasmacytic Lymphoma and Waldenstrom's Macroglobulinemia MAY 2013 ‧ VOL. 5 ‧ NO. 3
Young Woman With Deep Vein Thrombosis NOVEMBER 2012 ‧ VOL. 4 ‧ NO. 6
Update in the Management of Indolent Lymphoma NOVEMBER 2011 ‧ VOL. 3 ‧ NO. 6
Treatment Options for Patients With Immune Thrombocytopenia MAY 2010 ‧ VOL. 2 ‧ NO. 3
Update on Management of Myelodysplastic Syndromes APRIL 2009 ‧ VOL. 1 ‧ NO. 2